Financial Performance - Operating revenue for the period was ¥2,462,469,223.66, representing a year-on-year growth of 13.94%[6] - Net profit attributable to shareholders was ¥26,442,910.96, showing a significant increase of 96.02% compared to the same period last year[6] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥20,594,468.04, up 972.27% year-on-year[6] - Basic earnings per share doubled to ¥0.016, compared to ¥0.008 in the same period last year[6] - The weighted average return on equity increased by 0.25 percentage points to 0.50%[6] - The net profit for Q1 2018 reached CNY 24,733,984.98, representing a 99.5% increase from CNY 12,408,566.07 in Q1 2017[28] - The total profit for Q1 2018 was CNY 35,534,686.13, compared to CNY 19,006,774.33 in Q1 2017, showing an increase of 87%[28] Cash Flow - The net cash flow from operating activities was ¥277,337,768.48, a substantial increase of 2,988.10% compared to the previous year[6] - The total cash paid for operating activities rose by 102.02% to ¥569,707,167.41, indicating increased sales expenses[14] - Operating cash inflow totaled CNY 2,042,825,274.88, an increase from CNY 1,613,471,836.03 in the previous period, reflecting a growth of approximately 26.5%[33] - Cash outflow from financing activities reached CNY 2,496,769,852.50, compared to CNY 1,218,139,454.65 in the previous year, indicating a rise of about 104.5%[34] - The company reported a net cash flow from financing activities of -CNY 260,804,237.15, compared to a positive CNY 461,007,084.75 in the same period last year[37] Assets and Liabilities - Total assets at the end of the reporting period reached ¥17,165,902,090.59, a slight increase of 0.08% compared to the end of the previous year[6] - Total current assets reached ¥6,851,833,985.42, slightly up from ¥6,817,511,894.92 at the beginning of the year[18] - Non-current assets totaled CNY 7,325,222,754.26, an increase from CNY 6,812,843,563.00 at the beginning of the year, representing a growth of 7.49%[23] - Total liabilities amounted to CNY 10,408,388,960.62, up from CNY 9,744,709,161.46, reflecting an increase of 6.78%[24] - Current liabilities increased to CNY 7,503,135,011.72 from CNY 6,714,735,983.28, marking a rise of 11.74%[23] Shareholder Information - The total number of shareholders at the end of the reporting period was 82,855[10] - The top three shareholders held a combined total of 21.60%, 15.73%, and 15.33% of shares respectively[10] Expenses - Sales expenses surged by 155.94% to ¥582,115,991.81, driven by adjustments in marketing strategies and increased sales efforts[13] - The financial expenses for Q1 2018 were CNY 102,688,079.78, an increase from CNY 82,821,226.82, representing a rise of 24%[28] Investment and Income - The company reported a total of ¥5,848,442.92 in non-operating income for the period[9] - The investment income for Q1 2018 was CNY 8,664,352.30, up from CNY 7,997,797.43, reflecting an increase of 8.3%[28]
华北制药(600812) - 2018 Q1 - 季度财报